schliessen

Filtern

 

Bibliotheken

Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia

The hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of tre... Full description

Journal Title: European journal of clinical pharmacology 1992, Vol.42 (2), p.127-130
Main Author: VANHANEN, H
Other Authors: MIETTIEN, T. A
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: Heidelberg: Springer
ID: ISSN: 0031-6970
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_73036487
title: Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
format: Article
creator:
  • VANHANEN, H
  • MIETTIEN, T. A
subjects:
  • Adult
  • Aged
  • Biological and medical sciences
  • Cholesterol - analogs & derivatives
  • Cholesterol - biosynthesis
  • Cholesterol - blood
  • Cholesterol, LDL - blood
  • Desmosterol - blood
  • Female
  • General and cellular metabolism. Vitamins
  • Humans
  • Hyperlipoproteinemia Type II - blood
  • Hyperlipoproteinemia Type II - drug therapy
  • Isomerism
  • Lovastatin - administration & dosage
  • Lovastatin - therapeutic use
  • Male
  • Medical sciences
  • Middle Aged
  • Pharmacology. Drug treatments
  • Phytosterols
  • Pravastatin - administration & dosage
  • Pravastatin - therapeutic use
  • Sitosterols - blood
  • Triglycerides - blood
ispartof: European journal of clinical pharmacology, 1992, Vol.42 (2), p.127-130
description: The hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of treatment was similar after pravastatin (-23%, -32% and -32%) and lovastatin (-23%, -30% and -31%). The serum concentrations of LDL cholesterol were similarly reduced, whilst triglycerides, other lipoproteins, cholestanol and squalene were not altered. The reductions in the serum levels of the cholesterol precursor sterols, delta 8-cholesterol, desmosterol and lathosterol were not significantly different after either drug. The lack of difference suggests that cholesterol synthesis was equally inhibited by the two agents. In addition, the serum content of the plant sterols campesterol and sitosterol tended to be equally increased. The comparability of the increases suggests that the absorption and biliary elimination of the two sterols were equally affected by the two statins. Thus, no difference was found between the effects of pravastatin and lovastatin on the serum levels and metabolic precursors of cholesterol in FH during four weeks of treatment.
language: eng
source:
identifier: ISSN: 0031-6970
fulltext: no_fulltext
issn:
  • 0031-6970
  • 1432-1041
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK1.6122543
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_cross
recordidTN_cdi_proquest_miscellaneous_73036487
sourceformatXML
sourcesystemPC
sourcerecordid73036487
originalsourceidFETCH-LOGICAL-c241t-998726f585a575788c3855e630015ef94f034eaed4775c01c417aee5c03317e40
addsrcrecordideNptkMtLxDAQxoMouj4u3oUcxINQnTRJ0x5VfIGgBz2XMTvFSNquSSvuf2_WXVTE08wwv28eH2P7Ak4EgDk9vwLITakMrLGJUDLPBCixziYAUmRFZWCLbcf4CiB0BXKTbYpClLkSE_bxEPAd44CD6zh2U-777zK61nkMfs4DTUdLPFIYW25fek9xoND7L4UbIp8FsmOIfeCe3slHnuQNJrlDz1_mMwq_VEitw1220aCPtLeKO-zp6vLx4ia7u7--vTi7y2y6b8iqqjR50ehSozbalKWVpdZUyMUv1FSqAakIaaqM0RaEVcIgUUqlFIYU7LCj5dxZ6N_GdEHdumjJe-yoH2NtJMhClSaBx0vQhj7GQE09C67FMK8F1Aub6x-bE3ywmjo-tzT9QZe-pv7hqo_Rom8CdtbFb0znoKqqShj82Wndwvu-GwI6_9_mTy-BlZI
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid73036487
display
typearticle
titlePravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
creatorVANHANEN, H ; MIETTIEN, T. A
creatorcontribVANHANEN, H ; MIETTIEN, T. A
descriptionThe hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of treatment was similar after pravastatin (-23%, -32% and -32%) and lovastatin (-23%, -30% and -31%). The serum concentrations of LDL cholesterol were similarly reduced, whilst triglycerides, other lipoproteins, cholestanol and squalene were not altered. The reductions in the serum levels of the cholesterol precursor sterols, delta 8-cholesterol, desmosterol and lathosterol were not significantly different after either drug. The lack of difference suggests that cholesterol synthesis was equally inhibited by the two agents. In addition, the serum content of the plant sterols campesterol and sitosterol tended to be equally increased. The comparability of the increases suggests that the absorption and biliary elimination of the two sterols were equally affected by the two statins. Thus, no difference was found between the effects of pravastatin and lovastatin on the serum levels and metabolic precursors of cholesterol in FH during four weeks of treatment.
identifier
0ISSN: 0031-6970
1EISSN: 1432-1041
2DOI: 10.1007/BF00278470
3PMID: 1618241
languageeng
publisherHeidelberg: Springer
subjectAdult ; Aged ; Biological and medical sciences ; Cholesterol - analogs & derivatives ; Cholesterol - biosynthesis ; Cholesterol - blood ; Cholesterol, LDL - blood ; Desmosterol - blood ; Female ; General and cellular metabolism. Vitamins ; Humans ; Hyperlipoproteinemia Type II - blood ; Hyperlipoproteinemia Type II - drug therapy ; Isomerism ; Lovastatin - administration & dosage ; Lovastatin - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Phytosterols ; Pravastatin - administration & dosage ; Pravastatin - therapeutic use ; Sitosterols - blood ; Triglycerides - blood
ispartofEuropean journal of clinical pharmacology, 1992, Vol.42 (2), p.127-130
rights1992 INIST-CNRS
lds50peer_reviewed
citedbyFETCH-LOGICAL-c241t-998726f585a575788c3855e630015ef94f034eaed4775c01c417aee5c03317e40
citesFETCH-LOGICAL-c241t-998726f585a575788c3855e630015ef94f034eaed4775c01c417aee5c03317e40
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5204999$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1618241$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0VANHANEN, H
1MIETTIEN, T. A
title
0Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
1European journal of clinical pharmacology
addtitleEur J Clin Pharmacol
descriptionThe hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of treatment was similar after pravastatin (-23%, -32% and -32%) and lovastatin (-23%, -30% and -31%). The serum concentrations of LDL cholesterol were similarly reduced, whilst triglycerides, other lipoproteins, cholestanol and squalene were not altered. The reductions in the serum levels of the cholesterol precursor sterols, delta 8-cholesterol, desmosterol and lathosterol were not significantly different after either drug. The lack of difference suggests that cholesterol synthesis was equally inhibited by the two agents. In addition, the serum content of the plant sterols campesterol and sitosterol tended to be equally increased. The comparability of the increases suggests that the absorption and biliary elimination of the two sterols were equally affected by the two statins. Thus, no difference was found between the effects of pravastatin and lovastatin on the serum levels and metabolic precursors of cholesterol in FH during four weeks of treatment.
subject
0Adult
1Aged
2Biological and medical sciences
3Cholesterol - analogs & derivatives
4Cholesterol - biosynthesis
5Cholesterol - blood
6Cholesterol, LDL - blood
7Desmosterol - blood
8Female
9General and cellular metabolism. Vitamins
10Humans
11Hyperlipoproteinemia Type II - blood
12Hyperlipoproteinemia Type II - drug therapy
13Isomerism
14Lovastatin - administration & dosage
15Lovastatin - therapeutic use
16Male
17Medical sciences
18Middle Aged
19Pharmacology. Drug treatments
20Phytosterols
21Pravastatin - administration & dosage
22Pravastatin - therapeutic use
23Sitosterols - blood
24Triglycerides - blood
issn
00031-6970
11432-1041
fulltextfalse
rsrctypearticle
creationdate1992
recordtypearticle
recordideNptkMtLxDAQxoMouj4u3oUcxINQnTRJ0x5VfIGgBz2XMTvFSNquSSvuf2_WXVTE08wwv28eH2P7Ak4EgDk9vwLITakMrLGJUDLPBCixziYAUmRFZWCLbcf4CiB0BXKTbYpClLkSE_bxEPAd44CD6zh2U-777zK61nkMfs4DTUdLPFIYW25fek9xoND7L4UbIp8FsmOIfeCe3slHnuQNJrlDz1_mMwq_VEitw1220aCPtLeKO-zp6vLx4ia7u7--vTi7y2y6b8iqqjR50ehSozbalKWVpdZUyMUv1FSqAakIaaqM0RaEVcIgUUqlFIYU7LCj5dxZ6N_GdEHdumjJe-yoH2NtJMhClSaBx0vQhj7GQE09C67FMK8F1Aub6x-bE3ywmjo-tzT9QZe-pv7hqo_Rom8CdtbFb0znoKqqShj82Wndwvu-GwI6_9_mTy-BlZI
startdate1992
enddate1992
creator
0VANHANEN, H
1MIETTIEN, T. A
generalSpringer
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
97X8
sort
creationdate1992
titlePravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
authorVANHANEN, H ; MIETTIEN, T. A
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c241t-998726f585a575788c3855e630015ef94f034eaed4775c01c417aee5c03317e40
rsrctypearticles
prefilterarticles
languageeng
creationdate1992
topic
0Adult
1Aged
2Biological and medical sciences
3Cholesterol - analogs & derivatives
4Cholesterol - biosynthesis
5Cholesterol - blood
6Cholesterol, LDL - blood
7Desmosterol - blood
8Female
9General and cellular metabolism. Vitamins
10Humans
11Hyperlipoproteinemia Type II - blood
12Hyperlipoproteinemia Type II - drug therapy
13Isomerism
14Lovastatin - administration & dosage
15Lovastatin - therapeutic use
16Male
17Medical sciences
18Middle Aged
19Pharmacology. Drug treatments
20Phytosterols
21Pravastatin - administration & dosage
22Pravastatin - therapeutic use
23Sitosterols - blood
24Triglycerides - blood
toplevelpeer_reviewed
creatorcontrib
0VANHANEN, H
1MIETTIEN, T. A
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8MEDLINE - Academic
jtitleEuropean journal of clinical pharmacology
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0VANHANEN, H
1MIETTIEN, T. A
formatjournal
genrearticle
ristypeJOUR
atitlePravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
jtitleEuropean journal of clinical pharmacology
addtitleEur J Clin Pharmacol
date1992
risdate1992
volume42
issue2
spage127
epage130
pages127-130
issn0031-6970
eissn1432-1041
abstractThe hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of treatment was similar after pravastatin (-23%, -32% and -32%) and lovastatin (-23%, -30% and -31%). The serum concentrations of LDL cholesterol were similarly reduced, whilst triglycerides, other lipoproteins, cholestanol and squalene were not altered. The reductions in the serum levels of the cholesterol precursor sterols, delta 8-cholesterol, desmosterol and lathosterol were not significantly different after either drug. The lack of difference suggests that cholesterol synthesis was equally inhibited by the two agents. In addition, the serum content of the plant sterols campesterol and sitosterol tended to be equally increased. The comparability of the increases suggests that the absorption and biliary elimination of the two sterols were equally affected by the two statins. Thus, no difference was found between the effects of pravastatin and lovastatin on the serum levels and metabolic precursors of cholesterol in FH during four weeks of treatment.
cop
0Heidelberg
1Berlin
pubSpringer
pmid1618241
doi10.1007/BF00278470